|
|
||||||||||||||||
|
|
|
|
|
|||||||||||||
|
|
Control and Prevention Division of Cancer Prevention and Control 4770 Buford Hwy, NE MS K-64 Atlanta, GA 30341-3717 Call: 1 (800) CDC-INFO TTY: 1 (888) 232-6348 FAX: (770) 488-4760 E-mail: cdcinfo@cdc.gov Submit a Question Online |
|
|
|
Sharing the Decision Slide Set: Slide 15
Slide 15 — Key Issues of Screening and Early TreatmentTalking PointsFor the next several slides, we'll look at evidence regarding three key questions that address whether there is value in screening:
The best evidence for examining the benefits and harms of screening comes from controlled clinical trials that randomize men to screening or no screening, then follow them over several years to look for differences in mortality and quality of life. Two randomized controlled trials are now underway, but it will be several years before they are complete. In the meantime, we'll look at other evidence that can help us decide about the benefits and harms of screening. Text Description of SlidePlease refer to the "Talking Points" above.
Page last reviewed: September 26, 2006
Page last updated: September 26, 2006 Content source: Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion |
|
||||||||||||
|